Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. (Q45962743)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. |
scientific article |
Statements
1 reference
Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. (English)
1 reference
Alexandre Mebazaa
1 reference
Alain Cohen-Solal
1 reference
Damien Logeart
1 reference
Bidan Huang
1 reference
Danlin Cai
1 reference
Markku S Nieminen
1 reference
1 June 2009
1 reference
53
1 reference
25
1 reference
2343-2348
1 reference
Identifiers
1 reference
1 reference